Skip to content

Evaluation of the analgesic effect of preoperative pregabalin in impacted mandibular third molar surgery

Evaluation of the preoperative Pregabalin effects on the severity of pain after impacted mandibular third molar surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240515061810N1
Enrollment
24
Registered
2024-06-11
Start date
2024-06-19
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after mandibular wisdom tooth surgery.

Interventions

Intervention group: In the intervention group, the patient will be given an oral capsule pregabalin (a structural analogue of gamma-aminobutyric acid) 75 mg (Actoverco company) along with 50 mL of wat

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 51 Years

Inclusion criteria

Inclusion criteria: Individuals aged between 18 to 50 years with impacted mandibular third molars and similar degrees of mesioangular impaction.

Exclusion criteria

Exclusion criteria: Systemic diseases (e.g., osteoporosis, hyperparathyroidism, chronic kidney disease, connective tissue autoimmune diseases, diabetes, thyroid disorders, etc.). Use of medications that may interact with pregabalin (e.g., sedatives, muscle relaxants, anxiolytics, antidepressants, anticonvulsants, oral diabetes medications, and angiotensin inhibitors). History of alcohol addiction. Allergy to pregabalin or related drugs Pregnancy and lactation. Use of analgesic or anti-inflammatory drugs within 24 hours prior to surgery. Clinical or radiographic evidence of active oral inflammation.

Design outcomes

Primary

MeasureTime frame
Pain score on the Visual Analog Scale (VAS). Timepoint: 2, 4, 6, and 8 hours after the surgery. Method of measurement: Visual Analog Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHaleh zokaee

Gorgan University of Medical Sciences

Haleh.zokaee@gmail.com+98 17 3262 7824

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026